Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

57.04

+0.49 (0.87%)

as of Jun 25, 2026, 8:00:00 pm Market Open.

1634 watching

Investor Insights

Jun 25, 2026, 12:00 am

This summary was created by AI, based on 28 opinions in the last 12 months.

Manulife Financial (MFC) has garnered mixed opinions from market experts. Many analysts recognize MFC's potential, particularly highlighting its growth in Asia and successful capital generation from legacy businesses. The consensus seems to indicate a solid long-term investment due to its steady dividend yield, with several experts suggesting that patience may be required as the stock navigates short-term fluctuations. Despite some concerns about past performance and market positioning against competitors, the company's strategy and management is viewed positively. Analysts mention the current valuation as reasonable compared to peers, suggesting MFC is a better option for income rather than growth. Overall, there is a cautious optimism about MFC's capabilities and future direction.

Consensus

Hold

Valuation

Fair Value

Similar

SLF-T

BUY

MFC vs. SLF When he values lifecos, it's on price to book, dividend yield, or price to earnings, rather than price to cash flows. Sun Life trades at a premium. His preferred lifeco is Manulife, because of a discounted valuation plus a better business overall because of its Asian business. Wealth management is also better, and getting a handle on legacy businesses.

TOP PICK

It hit a 52 week high yesterday. There is potential for a resolution for some of their long term holdings. They are growing in Asia, where there are higher margins. It trades at a sizable valuation discount to its peers in the space. Yield 3.63% (Analysts’ price target is $30.33)

BUY

Recent break-out Jan. 23 to mid-April is the lifecos' (and banks') seasonality. The chart is setting up for a break-out as MFC approaches its highs of early-2018. Chart looks very good, and MFC will do pretty well.

TOP PICK

Superb dividend at 3.73%. Earning have steadily been rising and yet the price hasn't budged much in past year. Its rising fair market value is a good sign and it may go higher. (Analysts’ price target is $30.33)

PAST TOP PICK

(A Top Pick Jan 15/19, Up 33%) You never know when is going to have a good year. They had been increasing their dividend on flat performance so the yield going into last year was well over 4%. He thinks the new management team is doing the right things. It is still discounted relative to its peers. We are unlikely to see another year of 33%.

BUY

It is a good company and he thinks it is going higher. They seem to be on a bit of a roll. You could take some profits if you wanted to.

BUY

MFC vs. CM They were late to get US exposure, which hurt them. Also, there's negativity towards CM's mortgage book. TD and RY remain the top Canadian banks, not CM. TD & RY are investing in tech, the future, which is smart. MFC: The lifecos have done well diversifying into asset management and into Asia. But with low interest rates, pricing insurance gets tougher and limits growth. You own lifecos for Asia and wealth management. Not CM, but buy TD and Royal.

BUY

We had a nice little bottom from August. It is at resistance. $26 has been a resistance since early 2018. As long as the stock market goes higher, it will be good for MFC-T. He likes the insurers over the financials. He only like US financials better that Canadian insurance companies. See his Top Picks today. (Analysts’ price target is $30.00)

Wealthica Track your Stocks in your Watch List

COMMENT

Canada has four major life insurance companies. Since the financial crisis, Sun Life aas done the best. He does not see much change at Manulife so would prefer Sun Life.

COMMENT

Enter now for the long term? When interest rates are down, they hurt lifecos. But MFC beat their numbers handily last quarter. Asian operations are strong. He's neutral on insurance companies, because rates are so low. However, their valuation is cheap--but also cheap for so long. In 2020, he'll look at the lifecos again. Problem with lifecos is they're like a black box--you don't know what's inside sometimes.

HOLD

The history of what happened 10 years ago weighs on the minds of institutional investors. It is frustrating. At some point in time they should figure out a way to recognize the value.

BUY

MFC vs. SLF They're both good and relatively safe. They both have asset management businesses. Earnings growth will be 7-11% in 2020, which is far higher than the 1-3% for the banks. Also, they trade at single-digit multiples, cheap. According to book value, SLF is far more expensive, so he prefers MFC. MFC has more upside than SLF, but you're splitting hairs with these two.

TOP PICK

Pays a nice dividend. FMV is way above the current price, 167% higher. Good Balance sheet. Book value is in an uptrend. PB is very cheap. $26.50 is resistance, so watch that, but it has busted past that before. If so, it should reach $31-32. Are expanding international. Growing earnings. What's not to like. (Analysts’ price target is $29.91)

HOLD

The lifecos have done well this year, especially Sun-Life. Both offer relative safety and growth in Asia, especially MFC. Manulife isn't a tax-loss selling candidate.

COMMENT

He’s not sure about the next few months. Long term, they have growth potential in Asia. Interest rate is a bigger issue with insurance companies. The near term performance is closely related to interest rates so it depends how you think rates will go.

Showing 331 to 345 of 2,281 entries

Most Recent Experts

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Greg Newman

Scotia Wealth Management

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Brendan Caldwell

Caldwell Securities

Liz Young, Head of investment strategy at SoFi

SoFi

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)